Andrea Chipman

A randomised trial of the NHS-Galleri early detection blood test did not find a statistically significant reduction in the rate of stage III or IV cancers after three annual screening rounds.

Elective whole-pelvic radiotherapy does not have an overall survival benefit in unselected patients with clinically node-negative high-risk prostate cancer, new study findings suggest.

Exposure to helicobactor pylori H. pylori ) bacteria may be associated with a 59% increased risk of colorectal cancer (CRC), a study has found.

Researchers have developed a new risk stratification tool for patients with left-sided infective endocarditis (LSIE), to help inform MDT team discussions and assist with treatment decisions.

Patients with relapsing multiple sclerosis who were treated with ocrelizumab saw a long-term “significant and durable impact” on the course of their disease, latest data indicate.

Interstitial lung disease (ILD) can no longer be considered rare and should be recognised as a significant public health problem, researchers report.

A new study has linked transcatheter valve-in-valve implantation (ViV-TAVR) for degenerated bioprosthetic aortic valve repair with significantly better short-term outcomes than redo surgical aortic valve replacement (redo-SAVR).

Stereotactic arrhythmia radioablation (STAR) can cut the burden of refractory ventricular tachycardia and reduce ICD shocks, research has found

PSMA PET/CT-targeted biopsy (PET-TB) enhances detection of prostate cancer compared with systematic biopsy in men with negative or inconclusive MRI findings and persistent clinical risk factors, new research has shown.

New research has found a significant association between greater use of epilepsy-related healthcare and increased risk of young onset dementia (YOD).